Niagen Bioscience, Inc. - NAGE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Chief Executive Officer | A | A | 503,937.0 | 0.0 | 0.0 | 503,937.0 | View | |
| Feb 24, 2026 | Chief Financial Officer | A | A | 62,131.0 | 0.0 | 0.0 | 62,131.0 | View | |
| Feb 24, 2026 | SVP, General Counsel | A | A | 41,420.0 | 0.0 | 0.0 | 41,420.0 | View | |
| Nov 17, 2025 | Chief Financial Officer | P | A | 2,220.44 | 6.85 | 15,210.03 | 2,220.44 | View | |
| Nov 17, 2025 | Chief Financial Officer | P | A | 4,464.96 | 6.81 | 30,406.39 | 7,372.16 | View |